The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Neo-Endorphin Market Research Report 2025
Synopsis
The global Neo-Endorphin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
This report aims to provide a comprehensive presentation of the global market for Neo-Endorphin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neo-Endorphin.
Report Scope
The Neo-Endorphin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neo-Endorphin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neo-Endorphin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Segment by Application
Scientific Research
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neo-Endorphin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neo-Endorphin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Neo-Endorphin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
This report aims to provide a comprehensive presentation of the global market for Neo-Endorphin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neo-Endorphin.
Report Scope
The Neo-Endorphin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Neo-Endorphin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neo-Endorphin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
Segment by Type
α-Neo-Endorphin
β-Neo-Endorphin
Segment by Application
Scientific Research
Medical
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Neo-Endorphin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Neo-Endorphin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Neo-Endorphin Market Overview
1.1 Product Overview and Scope of Neo-Endorphin
1.2 Neo-Endorphin Segment by Type
1.2.1 Global Neo-Endorphin Market Value Comparison by Type (2024-2030)
1.2.2 α-Neo-Endorphin
1.2.3 β-Neo-Endorphin
1.3 Neo-Endorphin Segment by Application
1.3.1 Global Neo-Endorphin Market Value by Application: (2024-2030)
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Global Neo-Endorphin Market Size Estimates and Forecasts
1.4.1 Global Neo-Endorphin Revenue 2019-2030
1.4.2 Global Neo-Endorphin Sales 2019-2030
1.4.3 Global Neo-Endorphin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Neo-Endorphin Market Competition by Manufacturers
2.1 Global Neo-Endorphin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Neo-Endorphin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Neo-Endorphin Average Price by Manufacturers (2019-2024)
2.4 Global Neo-Endorphin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Neo-Endorphin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neo-Endorphin, Product Type & Application
2.7 Neo-Endorphin Market Competitive Situation and Trends
2.7.1 Neo-Endorphin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neo-Endorphin Players Market Share by Revenue
2.7.3 Global Neo-Endorphin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neo-Endorphin Retrospective Market Scenario by Region
3.1 Global Neo-Endorphin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Neo-Endorphin Global Neo-Endorphin Sales by Region: 2019-2030
3.2.1 Global Neo-Endorphin Sales by Region: 2019-2024
3.2.2 Global Neo-Endorphin Sales by Region: 2025-2030
3.3 Global Neo-Endorphin Global Neo-Endorphin Revenue by Region: 2019-2030
3.3.1 Global Neo-Endorphin Revenue by Region: 2019-2024
3.3.2 Global Neo-Endorphin Revenue by Region: 2025-2030
3.4 North America Neo-Endorphin Market Facts & Figures by Country
3.4.1 North America Neo-Endorphin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Neo-Endorphin Sales by Country (2019-2030)
3.4.3 North America Neo-Endorphin Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neo-Endorphin Market Facts & Figures by Country
3.5.1 Europe Neo-Endorphin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Neo-Endorphin Sales by Country (2019-2030)
3.5.3 Europe Neo-Endorphin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neo-Endorphin Market Facts & Figures by Country
3.6.1 Asia Pacific Neo-Endorphin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Neo-Endorphin Sales by Country (2019-2030)
3.6.3 Asia Pacific Neo-Endorphin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Neo-Endorphin Market Facts & Figures by Country
3.7.1 Latin America Neo-Endorphin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Neo-Endorphin Sales by Country (2019-2030)
3.7.3 Latin America Neo-Endorphin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neo-Endorphin Market Facts & Figures by Country
3.8.1 Middle East and Africa Neo-Endorphin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Neo-Endorphin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Neo-Endorphin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Neo-Endorphin Sales by Type (2019-2030)
4.1.1 Global Neo-Endorphin Sales by Type (2019-2024)
4.1.2 Global Neo-Endorphin Sales by Type (2025-2030)
4.1.3 Global Neo-Endorphin Sales Market Share by Type (2019-2030)
4.2 Global Neo-Endorphin Revenue by Type (2019-2030)
4.2.1 Global Neo-Endorphin Revenue by Type (2019-2024)
4.2.2 Global Neo-Endorphin Revenue by Type (2025-2030)
4.2.3 Global Neo-Endorphin Revenue Market Share by Type (2019-2030)
4.3 Global Neo-Endorphin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Neo-Endorphin Sales by Application (2019-2030)
5.1.1 Global Neo-Endorphin Sales by Application (2019-2024)
5.1.2 Global Neo-Endorphin Sales by Application (2025-2030)
5.1.3 Global Neo-Endorphin Sales Market Share by Application (2019-2030)
5.2 Global Neo-Endorphin Revenue by Application (2019-2030)
5.2.1 Global Neo-Endorphin Revenue by Application (2019-2024)
5.2.2 Global Neo-Endorphin Revenue by Application (2025-2030)
5.2.3 Global Neo-Endorphin Revenue Market Share by Application (2019-2030)
5.3 Global Neo-Endorphin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Peptide Institute
6.1.1 Peptide Institute Corporation Information
6.1.2 Peptide Institute Description and Business Overview
6.1.3 Peptide Institute Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Peptide Institute Neo-Endorphin Product Portfolio
6.1.5 Peptide Institute Recent Developments/Updates
6.2 Abbexa
6.2.1 Abbexa Corporation Information
6.2.2 Abbexa Description and Business Overview
6.2.3 Abbexa Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Abbexa Neo-Endorphin Product Portfolio
6.2.5 Abbexa Recent Developments/Updates
6.3 Elabscience
6.3.1 Elabscience Corporation Information
6.3.2 Elabscience Description and Business Overview
6.3.3 Elabscience Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Elabscience Neo-Endorphin Product Portfolio
6.3.5 Elabscience Recent Developments/Updates
6.4 Biosynth Carbosynth
6.4.1 Biosynth Carbosynth Corporation Information
6.4.2 Biosynth Carbosynth Description and Business Overview
6.4.3 Biosynth Carbosynth Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Biosynth Carbosynth Neo-Endorphin Product Portfolio
6.4.5 Biosynth Carbosynth Recent Developments/Updates
6.5 Generon.co.uk
6.5.1 Generon.co.uk Corporation Information
6.5.2 Generon.co.uk Description and Business Overview
6.5.3 Generon.co.uk Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Generon.co.uk Neo-Endorphin Product Portfolio
6.5.5 Generon.co.uk Recent Developments/Updates
6.6 Phoenix Pharmaceuticals
6.6.1 Phoenix Pharmaceuticals Corporation Information
6.6.2 Phoenix Pharmaceuticals Description and Business Overview
6.6.3 Phoenix Pharmaceuticals Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Phoenix Pharmaceuticals Neo-Endorphin Product Portfolio
6.6.5 Phoenix Pharmaceuticals Recent Developments/Updates
6.7 Creative Peptides
6.6.1 Creative Peptides Corporation Information
6.6.2 Creative Peptides Description and Business Overview
6.6.3 Creative Peptides Neo-Endorphin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Creative Peptides Neo-Endorphin Product Portfolio
6.7.5 Creative Peptides Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neo-Endorphin Industry Chain Analysis
7.2 Neo-Endorphin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neo-Endorphin Production Mode & Process
7.4 Neo-Endorphin Sales and Marketing
7.4.1 Neo-Endorphin Sales Channels
7.4.2 Neo-Endorphin Distributors
7.5 Neo-Endorphin Customers
8 Neo-Endorphin Market Dynamics
8.1 Neo-Endorphin Industry Trends
8.2 Neo-Endorphin Market Drivers
8.3 Neo-Endorphin Market Challenges
8.4 Neo-Endorphin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Neo-Endorphin Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Neo-Endorphin Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Neo-Endorphin Market Competitive Situation by Manufacturers in 2023
Table 4. Global Neo-Endorphin Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Neo-Endorphin Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Neo-Endorphin Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Neo-Endorphin Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Neo-Endorphin Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Neo-Endorphin, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Neo-Endorphin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neo-Endorphin, Product Type & Application
Table 12. Global Key Manufacturers of Neo-Endorphin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neo-Endorphin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neo-Endorphin as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neo-Endorphin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Neo-Endorphin Sales by Region (2019-2024) & (K Units)
Table 18. Global Neo-Endorphin Sales Market Share by Region (2019-2024)
Table 19. Global Neo-Endorphin Sales by Region (2025-2030) & (K Units)
Table 20. Global Neo-Endorphin Sales Market Share by Region (2025-2030)
Table 21. Global Neo-Endorphin Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Neo-Endorphin Revenue Market Share by Region (2019-2024)
Table 23. Global Neo-Endorphin Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Neo-Endorphin Revenue Market Share by Region (2025-2030)
Table 25. North America Neo-Endorphin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Neo-Endorphin Sales by Country (2019-2024) & (K Units)
Table 27. North America Neo-Endorphin Sales by Country (2025-2030) & (K Units)
Table 28. North America Neo-Endorphin Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Neo-Endorphin Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Neo-Endorphin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Neo-Endorphin Sales by Country (2019-2024) & (K Units)
Table 32. Europe Neo-Endorphin Sales by Country (2025-2030) & (K Units)
Table 33. Europe Neo-Endorphin Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Neo-Endorphin Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Neo-Endorphin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Neo-Endorphin Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Neo-Endorphin Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Neo-Endorphin Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Neo-Endorphin Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Neo-Endorphin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Neo-Endorphin Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Neo-Endorphin Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Neo-Endorphin Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Neo-Endorphin Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Neo-Endorphin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Neo-Endorphin Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Neo-Endorphin Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Neo-Endorphin Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Neo-Endorphin Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Neo-Endorphin Sales (K Units) by Type (2019-2024)
Table 51. Global Neo-Endorphin Sales (K Units) by Type (2025-2030)
Table 52. Global Neo-Endorphin Sales Market Share by Type (2019-2024)
Table 53. Global Neo-Endorphin Sales Market Share by Type (2025-2030)
Table 54. Global Neo-Endorphin Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Neo-Endorphin Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Neo-Endorphin Revenue Market Share by Type (2019-2024)
Table 57. Global Neo-Endorphin Revenue Market Share by Type (2025-2030)
Table 58. Global Neo-Endorphin Price (US$/Unit) by Type (2019-2024)
Table 59. Global Neo-Endorphin Price (US$/Unit) by Type (2025-2030)
Table 60. Global Neo-Endorphin Sales (K Units) by Application (2019-2024)
Table 61. Global Neo-Endorphin Sales (K Units) by Application (2025-2030)
Table 62. Global Neo-Endorphin Sales Market Share by Application (2019-2024)
Table 63. Global Neo-Endorphin Sales Market Share by Application (2025-2030)
Table 64. Global Neo-Endorphin Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Neo-Endorphin Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Neo-Endorphin Revenue Market Share by Application (2019-2024)
Table 67. Global Neo-Endorphin Revenue Market Share by Application (2025-2030)
Table 68. Global Neo-Endorphin Price (US$/Unit) by Application (2019-2024)
Table 69. Global Neo-Endorphin Price (US$/Unit) by Application (2025-2030)
Table 70. Peptide Institute Corporation Information
Table 71. Peptide Institute Description and Business Overview
Table 72. Peptide Institute Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Peptide Institute Neo-Endorphin Product
Table 74. Peptide Institute Recent Developments/Updates
Table 75. Abbexa Corporation Information
Table 76. Abbexa Description and Business Overview
Table 77. Abbexa Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Abbexa Neo-Endorphin Product
Table 79. Abbexa Recent Developments/Updates
Table 80. Elabscience Corporation Information
Table 81. Elabscience Description and Business Overview
Table 82. Elabscience Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Elabscience Neo-Endorphin Product
Table 84. Elabscience Recent Developments/Updates
Table 85. Biosynth Carbosynth Corporation Information
Table 86. Biosynth Carbosynth Description and Business Overview
Table 87. Biosynth Carbosynth Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Biosynth Carbosynth Neo-Endorphin Product
Table 89. Biosynth Carbosynth Recent Developments/Updates
Table 90. Generon.co.uk Corporation Information
Table 91. Generon.co.uk Description and Business Overview
Table 92. Generon.co.uk Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Generon.co.uk Neo-Endorphin Product
Table 94. Generon.co.uk Recent Developments/Updates
Table 95. Phoenix Pharmaceuticals Corporation Information
Table 96. Phoenix Pharmaceuticals Description and Business Overview
Table 97. Phoenix Pharmaceuticals Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Phoenix Pharmaceuticals Neo-Endorphin Product
Table 99. Phoenix Pharmaceuticals Recent Developments/Updates
Table 100. Creative Peptides Corporation Information
Table 101. Creative Peptides Description and Business Overview
Table 102. Creative Peptides Neo-Endorphin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Creative Peptides Neo-Endorphin Product
Table 104. Creative Peptides Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Neo-Endorphin Distributors List
Table 108. Neo-Endorphin Customers List
Table 109. Neo-Endorphin Market Trends
Table 110. Neo-Endorphin Market Drivers
Table 111. Neo-Endorphin Market Challenges
Table 112. Neo-Endorphin Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neo-Endorphin
Figure 2. Global Neo-Endorphin Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Neo-Endorphin Market Share by Type in 2023 & 2030
Figure 4. α-Neo-Endorphin Product Picture
Figure 5. β-Neo-Endorphin Product Picture
Figure 6. Global Neo-Endorphin Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Neo-Endorphin Market Share by Application in 2023 & 2030
Figure 8. Scientific Research
Figure 9. Medical
Figure 10. Others
Figure 11. Global Neo-Endorphin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Neo-Endorphin Market Size (2019-2030) & (US$ Million)
Figure 13. Global Neo-Endorphin Sales (2019-2030) & (K Units)
Figure 14. Global Neo-Endorphin Average Price (US$/Unit) & (2019-2030)
Figure 15. Neo-Endorphin Report Years Considered
Figure 16. Neo-Endorphin Sales Share by Manufacturers in 2023
Figure 17. Global Neo-Endorphin Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Neo-Endorphin Players: Market Share by Revenue in 2023
Figure 19. Neo-Endorphin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Neo-Endorphin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Neo-Endorphin Sales Market Share by Country (2019-2030)
Figure 22. North America Neo-Endorphin Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Neo-Endorphin Sales Market Share by Country (2019-2030)
Figure 26. Europe Neo-Endorphin Revenue Market Share by Country (2019-2030)
Figure 27. Germany Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Neo-Endorphin Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Neo-Endorphin Revenue Market Share by Region (2019-2030)
Figure 34. China Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Neo-Endorphin Sales Market Share by Country (2019-2030)
Figure 45. Latin America Neo-Endorphin Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Neo-Endorphin Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Neo-Endorphin Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Neo-Endorphin Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Neo-Endorphin by Type (2019-2030)
Figure 55. Global Revenue Market Share of Neo-Endorphin by Type (2019-2030)
Figure 56. Global Neo-Endorphin Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Neo-Endorphin by Application (2019-2030)
Figure 58. Global Revenue Market Share of Neo-Endorphin by Application (2019-2030)
Figure 59. Global Neo-Endorphin Price (US$/Unit) by Application (2019-2030)
Figure 60. Neo-Endorphin Value Chain
Figure 61. Neo-Endorphin Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
